Accès ouvert
2025
article
OpenAlex
Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Kaja Abbas et autres
BACKGROUND: Sotrovimab is a neutralising monoclonal antibody targeting the SARS-CoV-2 spike protein. We aimed to evaluate the efficacy and safety of sotrovimab in the RECOVERY trial, an investigator-initiated, individually randomised, controlled, open-label, adaptive platform trial testing treatments for patients admitted to hospital …
Accès ouvert
2025
article
OpenAlex
Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Jonathan Raihan Abbas et autres
BACKGROUND: Molnupiravir and nirmatrelvir-ritonavir are oral antivirals that have shown efficacy in preventing disease progression in outpatients with COVID-19. We aimed to evaluate these treatments for patients hospitalised with COVID-19 pneumonia, for whom data on these antivirals are scarce. METHODS: The RECOVERY …
Accès ouvert
2025
article
OpenAlex
Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Jaffar Abbas et autres
Background: Low dose corticosteroids (e.g., 6 mg dexamethasone) have been shown to reduce mortality for hypoxic COVID-19 patients. We have previously reported that higher dose corticosteroids cause harm in patients with clinical hypoxia but not receiving ventilatory support (the combination of non-invasive …
2024
conference-paper
OpenAlex
Arani Nitkunan, B Ajay, Schon Fred
Croydon University Hospital is a district general hospital serving a population of 380,000. We have been trying to progressively improve our acute neurology services and present key features from our latest 9 year data with previous publication of others - the vital …
gb
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Saul N. Faust, Richard Haynes, Christine Elizabeth Jones, Natalie Staplin et autres
BACKGROUND: Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children (MIS-C) emerged in April, 2020. The paediatric comparisons within the RECOVERY trial aimed to assess the effect of intravenous immunoglobulin or corticosteroids compared with …
us, de, gb
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Jonathan Raihan Abbas et autres
BACKGROUND: Empagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic, and haemodynamic effects. The RECOVERY trial aimed to assess its safety and efficacy in patients admitted to hospital with COVID-19. METHODS: In the randomised, controlled, …
2023
article
OpenAlex
Sumedha Dondapati, Iniyan Selvamani, B Ajay, R. Maathanghi et autres
Introduction: With the sudden onset of COVID 19, many organisations introduced a mandatory relocation of workforce from their workplace to their homes bringing in a work from home policy for their employees. The purpose of the study is to examine the positive …
in
(code pays fourni par la source)
2017
article
OpenAlex
Liyakat Ali Gauri, Qadir Fatima, Sharanbasu Diggi, Asim Khan et autres
INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis.1-3 People with rheumatoid arthritis are at increased risk of osteoporosis. Hence this article intends to highlight the importance of BMD measurement in patients with …
mm, in, us
(code pays fourni par la source)
2012
conference-abstract
OpenAlex
Ewelina Rzyska, B Ajay, Edwin Chandraharan
2012
article
OpenAlex
Sarantos Kaptanis, L Chetouani, Sagar S. Damle, B Ajay
gb
(code pays fourni par la source)